A potential breakthrough in cardiovascular medicine has emerged with the development of lepodisiran, an experimental drug by pharmaceutical company Eli Lilly.The drug has demonstrated...
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, accounting for 32 per cent of global fatalities. According to statistics from the World...